Status:
UNKNOWN
Whole Exome Screening of Newborns
Lead Sponsor:
Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare
Conditions:
Infant, Newborn
Eligibility:
All Genders
Brief Summary
The aim of the study is to obtain the initial experience of the inclusive genetic screening of newborn. Two groups of newborns born in RCOGP will be enlisted to the study: 1. newborns without develo...
Eligibility Criteria
Inclusion
- Group 1 (newborns without features):
- Infants born in the RCOGP, showing no development features and with no inherited diseases revealed by common screening
- Informed consent signed by a newborn's representative
Exclusion
- Parents refuse to participate
- Parent(s) younger 18 years
- Parent(s) unable to make decisions
- The infant is older 30 d
- Blood cannot be collected from the infant
- Group 2 (newborns with phenotypic features)
- Inclusion Criteria:
- Infants showing either phenotypic features or deviations according to MS screening
- Informed consent signed by a newborn's representative
Key Trial Info
Start Date :
July 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
7000 Patients enrolled
Trial Details
Trial ID
NCT05325749
Start Date
July 10 2021
End Date
December 1 2022
Last Update
April 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare
Moscow, Russia, 117997